Vol. 26 - Num. 103
Evidence based Pediatrics
Elena Pérez Gonzáleza, Victoria Martínez Rubiob
aServicio de Pediatría. Hospital Universitario Virgen de la Macarena. Sevilla.
bPediatra. CS Los Fresnos. Torrejón de Ardoz. Madrid. España.
Correspondence: E Pérez . E-mail: pg.elena@gmail.com
Reference of this article: Pérez González E, Martínez Rubio V. Atropine eyedrops can prevent the onset and delay the progression of myopia in children . Rev Pediatr Aten Primaria. 2024;26:311-3. https://doi.org/10.60147/a0e2a88f
Published in Internet: 27-09-2024 - Visits: 1304
Abstract
Authors´ conclusions: nightly use of 0.05% atropine eyedrops among children aged 4 to 9 years without myopia resulted in a significantly lower incidence of myopia and lower percentage of participants with fast myopic shift at 2 years.
Reviewers´ commentary: this study, of adequate design and quality, concludes that atropine in low concentration helps prevent the onset and rapid progression of myopia in high-risk children, with few side effects. Long-term follow-up is pending to assess adequate follow-up time and possible rebound effect after suspension.
Keywords
● Atropine ● Child ● Myopia ● PreventionNote:
Este artículo se publica simultáneamente con la revista electrónica Evidencias en Pediatría (www.evidenciasenpediatria.es).
Comments
This article has no comments yet.